Gpe VIII Gp Limited Partnership Ap serves as Executive at Syneos Health, Inc., where they oversee executive responsibilities. Since joining the company, Gpe VIII Gp Limited Partnership Ap has executed 1 insider transactions totaling $36.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 14, 2021 involved selling 448,942 shares valued at $36.4M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 14, 2021 | SYNH | $36.4M | Sale | 448,942 | $81.04 | Discretionary |
Gpe VIII Gp Limited Partnership Ap currently holds 6,307,489 shares of Syneos Health, Inc. (SYNH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gpe VIII Gp Limited Partnership Ap has been a net seller of SYNH stock. They have purchased $0 and sold $36.4M worth of shares.
Gpe VIII Gp Limited Partnership Ap's most recent insider trade was on May 14, 2021, when they sold 448,942 shares at $81.04 per share.
Get notified when new Form 4 filings are submitted